VIR today
$9.92-$2.20 (-18.15%)close Nov 13, 2026Trend
DailyUptrend (confirmed)
4 hourStrong Bearish
1 hourExpanding
15 minStrong Bearish
5 minStrong Bearish
Daily trend turns down below $10.98
Key levels
Resistance$10.98
Resistance$10.03
Support$9.03
Support$8.16
Latest news & SEC filings
DealVir Biotechnology prices public offering of common stock
SEC FilingVir Biotechnology, Inc. filed an automatic shelf registration for future offerings (Form S-3ASR)
AnalystMorgan Stanley keeps Overweight on Vir Biotechnology, lifts target to $28
All VIR news →About Vir Biotechnology
Vir Biotechnology is a biopharmaceutical company focused on developing therapies and preventive options for dangerous infections, cancer, and other significant medical conditions. Its pipeline includes antibody-based candidates, and it employs technology platforms such as a proprietary AI engine for antibody discovery and engineering. The company operates in the United States and may pursue regulatory approvals in other countries. It works with partners and licenses technologies from other organizations.
Based on the company's 10-K filed Feb 23, 2026.
Nasdaq · Healthcare
Vir Biotechnology, Inc. (VIR)
What Is the Price Target for VIR?
SEPT Low Target
$18.70
SEPT Mid Target
$22.00
SEPT High Target
$25.30
Analyst Consensus
$22.00
Is VIR a Buy or Sell Right Now?
Thesis
- •Revenue growing -7.6% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for VIR.
Start Free Trial →Is VIR Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$20.31
25
Moat Score
NONE
2/9
Piotroski Score
1.5
Altman Z-Score
What Is Smart Money Doing with VIR?
Insider Signal
SELLING
0 buys / 10 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
DISTRIBUTING
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| de Verneuil Vanina | officer | Sale | 2,407 | $27K | Nov 3, 2026 |
| de Verneuil Vanina | officer | Sale | 1,343 | $15K | Nov 2, 2026 |
| Topalian Suzanne Louise | director | Buy | 8,000 | - | Oct 27, 2026 |
| Topalian Suzanne Louise | director | Buy | 4,731 | - | Oct 27, 2026 |
| Coughlin Timothy | director | Buy | 8,000 | - | Jun 9, 2026 |
| Napolitano Janet | director | Sale | 3,200 | $30K | Jun 1, 2026 |
| Sabatini Brent | officer | Sale | 379 | $4K | Jun 1, 2026 |
| Sigal Charles Elliott | director | Buy | 8,000 | - | May 27, 2026 |
| Napolitano Janet | director | Buy | 8,000 | - | May 27, 2026 |
| MORE ROBERT J | director | Buy | 8,000 | - | May 27, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →VIR Growth Story
Revenue YoY
-7.6%
3yr Revenue CAGR
-65.1%
EPS Growth YoY
17.49%
FCF Growth YoY
12.6%
Revenue Trend
ACCELERATING
Dark Pool Trades for VIR
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for VIR, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 19:19:09 | $9.94 | 1,400 | $$14K | BUY |
| 19:13:03 | $9.91 | 2,720 | $$27K | BUY |
| 19:11:15 | $9.91 | 1,000 | $$10K | SELL |
| 19:11:11 | $9.91 | 9,600 | $$95K | BUY |
| 19:10:30 | $9.93 | 1,000 | $$10K | SELL |
5 dark pool trades shown · $$156K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for VIR
PREVIEWSEPT Investing provides real-time options flow tracking for VIR, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $12 | Nov 20 | 7 | $$5 | 1 | SWEEP |
| PUT | $10 | Dec 18 | 35 | $$320 | 4 | SWEEP |
| CALL | $12 | Apr 16 | 154 | $$1080 | 8 | SWEEP |
| CALL | $12 | Apr 16 | 154 | $$1485 | 11 | SWEEP |
| CALL | $12 | Apr 16 | 154 | $$1350 | 10 | SWEEP |
5 options trades shown · 80% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Vir Biotechnology, Inc. (VIR) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (3 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →VIR — frequently asked questions
What is VIR stock price today?
Vir Biotechnology, Inc. (VIR) is at $9.92, down 18.15% (-$2.20) at the Nov 13, 2026 close.
Why is VIR stock moving today?
Latest VIR news — Nov 13, 2026: Vir Biotechnology prices public offering of common stock · Nov 12, 2026: Vir Biotechnology, Inc. filed an automatic shelf registration for future offerings (Form S-3ASR)
What is the VIR price target?
The average analyst price target for VIR is $22.00, ranging from $21 to $27, based on 3 analysts. Latest: HC Wainwright & Co. maintains on Oct 7, 2026.
What do analysts rate VIR?
Analyst ratings for VIR: 0 Buy, 3 Hold, 0 Sell — consensus Hold.
Did VIR beat earnings?
VIR last reported on Aug 5, 2026: EPS $0.47 vs $0.33 expected — a beat of 41.3%.
Does VIR pay a dividend?
VIR does not currently pay a dividend.
What are VIR support and resistance levels?
Support: $9.03, $8.16, $7.26. Resistance: $10.03, $10.98, $12.19.
What are insiders doing with VIR?
Insider activity: SELLING, 0 buys and 10 sells in the last 90 days.
What is the latest news on VIR?
Nov 13, 2026: Vir Biotechnology prices public offering of common stock · Nov 12, 2026: Vir Biotechnology, Inc. filed an automatic shelf registration for future offerings (Form S-3ASR) · Nov 10, 2026: Morgan Stanley keeps Overweight on Vir Biotechnology, lifts target to $28